| 标题 |
Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL) |
| 网址 | |
| DOI |
10.1182/blood-2025-778
doi
|
| 其它 |
期刊:Blood 作者:Richard Miller; Ryan Wilcox; John Reneau; Costas Yannakou; Won Seog Kim; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)